Gerald Berry, MD

Gerald Berry is a Professor of Pathology at the Stanford University Medical Center. He completed his medical education from University of Ottawa School of Medicine, Canada. He is board certified in pathology from American Board of Pathology and anatomic pathology from Royal College of Physicians and Surgeons of Canada.

He completed residency from Stanford University Surgical Pathology Fellowship, California, internship from Ottawa General Hospital, Canada and fellowship from Stanford University Pathology Residency, California.

His current research and scholarly interest include cardiopulmonary and pulmonary transplant medicine, and diagnostic surgical pathology.

Representative Publications:

Immunosuppressive Therapies for the Prevention and Treatment of Obliterative Airway Disease in Heterotopic Rat Trachea Allografts.
Effects of the New and Highly Active Immunosuppressant, Rapamycin, on Lymphoid Tissues and Cells in Vivo.
Combined Immunosuppression With Cyclosporine (Neoral) and Sdz Rad in Non-Human Primate Lung Transplantation: Systematic Pharmacokinetic-Based Trials to Improve Efficacy and Tolerability.
Treatment by Mycophenolate Mofetil of Advanced Graft Vascular Disease in Non-Human Primate Recipients of Orthotopic Aortic Allografts.
Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine